Copper complexes as candidate therapeutic agents against infiltrative glioblastoma cells
Open Access
- 18 November 2026
- journal article
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 17 (11) , 5663-5673
Abstract
Copper complexes yielded low μM IC 50 values in invasive glioblastoma cell lines. Created in BioRender. McCrorie, P. (2026) https://BioRender.com/gs8z4yq.Keywords
Funding Information
- University of Nottingham
- Brain Tumour Research (BTR-A-0145)
This publication has 43 references indexed in Scilit:
- The Anti‐Cancer Stem Cell Properties of Copper(II)‐Terpyridine Complexes with Attached Salicylaldehyde MoietiesChemBioChem, 2024
- Trace elements in pancreatic cancerCancer Medicine, 2024
- Cuproptosis: A novel therapeutic target for overcoming cancer drug resistanceDrug Resistance Updates, 2023
- Copper(II) Schiff base complexes: Synthetic and medicinal perspectiveInorganic Chemistry Communications, 2023
- Copper(I) iodide complex with 4-pyridinecarboxaldehyde ligand: Synthesis, spectroscopic characterisation, AIM and NCI analysis combined with molecular docking and antibacterial activity studiesJournal of Molecular Structure, 2022
- Synthesis, characterization, anticancer and antioxidant activity of new nickel(II) and copper(II) flavonoid complexesJournal of Molecular Structure, 2019
- Designing anticancer copper(II) complexes by optimizing 2-pyridine-thiosemicarbazone ligandsEuropean Journal of Medicinal Chemistry, 2018
- ROS-mediated autophagy was involved in cancer cell death induced by novel copper(II) complexExperimental and Toxicologic Pathology, 2010
- Metals in anticancer therapy: Copper(II) complexes as inhibitors of the 20S proteasomeEuropean Journal of Medicinal Chemistry, 2009
- EasySpin, a comprehensive software package for spectral simulation and analysis in EPRJournal of Magnetic Resonance, 2006